Clinigen Group
Rapidly-growing specialty pharmaceutical and services company,.
Launch date
Market cap
-
Enterprise valuation
AUD2.8b (Public information from Dec 2021)
Company register number 06771928
Branston England (HQ)
Financials
Estimates*
| GBP | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| EBITDA | 20.2m | 57.0m | 64.1m | 66.2m | 81.3m | 121m | 77.0m |
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | £50.0m Valuation: £135m | IPO |
* | $1.8b Valuation: $1.8b 16.6x EV/LTM EBITDA | Buyout | |
| Total Funding | - | ||
Related Content
Recent News about Clinigen Group
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Clinigen Group
Edit
ACQUISITION by Clinigen Group Apr 2015
ACQUISITION by Clinigen Group Sep 2017
ACQUISITION by Clinigen Group Sep 2018
ACQUISITION by Clinigen Group Jun 2024
ACQUISITION by Clinigen Group Dec 2022
ACQUISITION by Clinigen Group Jul 2024